Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Add in cart at a low figure generic pills no Rx, Fast delivery!

Need an affordable deal for the purchase of your Nitrofurantoin? Buy it at our online store for $0.6 only!

Read More »

Order at a low price medications no prescription, Low prices!

If you are still looking for your Chloramphenicol at a lower price than on the most of the market, you’ve found it! buy Chloramphenicol only for $0.65 right here!

Read More »

Switching course, Gilead markets HIV drug for prevention

Gilead Sciences Inc. has begun marketing its HIV treatment Truvada in a way thousands of consumers already use it – to prevent infection with the virus that causes AIDS.

Read More »

Want to delay death? Then swim, dance, or get on court, study shows

Swimming, racquet sports and aerobics are associated with the best odds of staving off death, and in particular of reducing the risk of dying from heart disease or stroke, scientists said.

Read More »

One in seven people with HIV in EU unaware they have virus: report

One in seven people with HIV in the Europe Union region is unaware they have the virus, seriously hampering efforts to meet a global 2030 deadline for eradicating the AIDS epidemic, a senior health expert said.

Read More »

Injections, implants tested as new weapons to prevent HIV

Scientists are taking the battle to prevent HIV to the next level with large-scale trials set to start using injections to protect vulnerable groups such as gay men and women in Africa for at least two months.

Read More »

Momenta’s Humira biosimilar succeeds in key psoriasis study

U.S. biotech Momenta Pharmaceuticals Inc. said its experimental biosimilar version of AbbVie Inc’s top-selling autoimmune drug, Humira, met the main goal in a late-stage trial involving patients with a form of psoriasis.

Read More »

Trump Debuts Healthcare Reform Dream Team

Tim Price was tapped as Secretary of Health and Human Services and Seema Verna will helm the Centers for Medicare and Medicaid Services per Senate approval.

Read More »

Amicus Faces 3-Year Delay for Fabry Drug

Shares of Amicus Therapeutics plunged more than 22 percent after the company was forced to lay out plans for another clinical trial for its lead drug candidate migalastat.

Read More »

Texas reports first case of Zika spread by local mosquitoes

Texas health officials reported the state’s first case of Zika likely spread by local mosquitoes, making Texas the second state within the continental United States to report local transmission of the virus that has been linked to birth defects.

Read More »

U.S. health bill expected to sail through House vote

The House of Reps is expected to pass a $6.3 billion piece of legislation designed to spur medical innovation, speed access to new drugs, expand mental health treatment, and combat opioid abuse.

Read More »

Pfizer Nixes €400 Million Ireland Expansion

Following the failure of the late-stage anti-cholesterol drug bococizumab, Pfizer cancelled plans to spend nearly $500 million to expand its Ireland manufacturing site.

Read More »

France finds H5N8 bird flu in wild ducks

A severe strain of H5N8 bird flu that has hit several countries in Europe leading to the culling of thousands of poultry was detected in wild ducks in Northern France, the farm ministry said.

Read More »

Novo Nordisk A/S Yanks Ads Off of Conservative Site Founded by New Chief Strategist Stephen Bannon

Danish drugmaker Novo Nordisk A/S pulled advertising from Breitbart, the online news site formerly helmed by Stephen Bannon, special adviser to President-elect Donald Trump.

Read More »

Latest Deaths in Juno Trial Puts Unwanted Limelight on the FDA

Does the U.S. Food and Drug Administration bear some culpability in the most recent deaths associated with Juno Therapeutics’ CART-T trial? Some industry observers and analysts seem to think so.

Read More »

Teva Pharm to market medical cannabis inhaler in Israel

Israel’s Teva Pharmaceutical Industries has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.

Read More »

Australian asthma storm claims sixth victim

A sixth person has died in the Australian city of Melbourne after a storm triggered thousands of pollen allergy asthma attacks, the Victorian state government said.

Read More »

Innate Pharma can remain independent, for now

France’s Innate Pharma believes that its cash position and portfolio are sufficiently robust for the cancer drug company to remain independent for the time being.

Read More »

Pharma Execs Need to Think More Like Entrepreneurs

Modern pharmacies have lost the personal touch that ma and pa shops once had as they grapple with a growing patient volume. Pharmaceutical executives would be wise to abandon their struggling system and adopt an entrepreneurial mindset.

Read More »

Sealed chamber brings wonders of nature to hospitalized kids

At North Carolina Children’s Hospital, immune-compromised kids can experience the natural environment while getting around hospital rules – digging in dirt, poking into pitcher plants and observing other wonders of nature otherwise prohibited – thanks to a new device called the WonderSphere.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom